Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för febuxostat. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2019-11-01

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients.

Li Y, Liu M, Zhang X, Lu Y, Meng J.

Ren Fail · research-article; journal article; observational study · DOI 10.1080/0886022x.2019.1632717

Bibliografisk träff 2019-09-24

Inhibition of xanthine oxidoreductase protects against contrast-induced renal tubular injury by activating adenosine monophosphate-activated protein kinase.

Yang KJ, Kim JH, Chang YK, Park CW, Kim SY, Hong YA.

Free Radic Biol Med · research support, non-u.s. gov't; journal article · DOI 10.1016/j.freeradbiomed.2019.09.027

Bibliografisk träff 2019-09-17

A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout.

Zhang F, Liu Z, Jiang L, Zhang H, Zhao D, Li Y, Zou H, Wang X, Li X, Shi B, Xu J, Yang H, Hu S, Qu S.

Rheumatol Ther · research-article; journal article · DOI 10.1007/s40744-019-00173-8

Bibliografisk träff 2019-09-06

Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice.

Amirshahrokhi K.

Int Immunopharmacol · journal article · DOI 10.1016/j.intimp.2019.105884

Bibliografisk träff 2019-09-01

Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data.

Singh JA, Cleveland JD.

Eur Heart J · comparative study; research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1093/eurheartj/ehz154

Bibliografisk träff 2019-08-26

The impact of adoption of a new urate-lowering agent on trends in utilization and cost in practice.

Peng YL, Lee CT, Tain YL, Huang YB, Chuang HY, Wen YH, Huang SH, Tsai CY, Hsu CN.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0221504

Bibliografisk träff 2019-07-22

Freeze-Dried Self-Nanoemulsifying Self-Nanosuspension (SNESNS): a New Approach for the Preparation of a Highly Drug-Loaded Dosage Form.

ElShagea HN, ElKasabgy NA, Fahmy RH, Basalious EB.

AAPS PharmSciTech · journal article · DOI 10.1208/s12249-019-1472-2

Bibliografisk träff 2019-07-01

Effects of febuxostat on renal function in patients with chronic kidney disease: A systematic review and meta-analysis.

Lin TC, Hung LY, Chen YC, Lo WC, Lin CH, Tam KW, Wu MY.

Medicine (Baltimore) · meta-analysis; systematic review; review-article; journal article · DOI 10.1097/md.0000000000016311

Bibliografisk träff 2019-07-01

Effects of febuxostat on atrial remodeling in a rabbit model of atrial fibrillation induced by rapid atrial pacing.

Fan YY, Xu F, Zhu C, Cheng WK, Li J, Shan ZL, Li Y, Wang YT.

J Geriatr Cardiol · research-article; journal article · DOI 10.11909/j.issn.1671-5411.2019.07.003

Bibliografisk träff 2019-06-24

The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia - A systematic review and meta-analysis.

Liu CW, Chang WC, Lee CC, Shau WY, Hsu FS, Wang ML, Chen TC, Lo C, Hwang JJ.

Nutr Metab Cardiovasc Dis · meta-analysis; research support, non-u.s. gov't; systematic review; journal article · DOI 10.1016/j.numecd.2019.06.016

Bibliografisk träff 2019-06-01

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.

Kojima S, Matsui K, Hiramitsu S, Hisatome I, Waki M, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Mori H, Sugawara M, Ohya Y, Kimura K, Saito Y, Ogawa H.

Eur Heart J · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1093/eurheartj/ehz119

Bibliografisk träff 2015-03-01

Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.

Frampton JE.

Drugs · review; journal article · DOI 10.1007/s40265-015-0360-7